569 related articles for article (PubMed ID: 26164785)
1. Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors.
Sayner R; Carpenter DM; Blalock SJ; Robin AL; Muir KW; Hartnett ME; Giangiacomo AL; Tudor G; Sleath B
Clin Ther; 2015 Sep; 37(9):1975-85. PubMed ID: 26164785
[TBL] [Abstract][Full Text] [Related]
2. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
[TBL] [Abstract][Full Text] [Related]
3. Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence.
Sleath B; Blalock SJ; Carpenter DM; Sayner R; Muir KW; Slota C; Lawrence SD; Giangiacomo AL; Hartnett ME; Tudor G; Goldsmith JA; Robin AL
Ophthalmology; 2015 Apr; 122(4):748-54. PubMed ID: 25542521
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of Self-reported Glaucoma Medication Adherence With a New Wireless Device: A Pilot Study.
Gatwood JD; Johnson J; Jerkins B
J Glaucoma; 2017 Nov; 26(11):1056-1061. PubMed ID: 29099436
[TBL] [Abstract][Full Text] [Related]
5. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
[TBL] [Abstract][Full Text] [Related]
6. The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey.
Newman-Casey PA; Robin AL; Blachley T; Farris K; Heisler M; Resnicow K; Lee PP
Ophthalmology; 2015 Jul; 122(7):1308-16. PubMed ID: 25912144
[TBL] [Abstract][Full Text] [Related]
7. Optimal recall period in assessing the adherence to antihypertensive therapy: a pilot study.
Doró P; Benko R; Czakó A; Matuz M; Thurzó F; Soós G
Int J Clin Pharm; 2011 Aug; 33(4):690-5. PubMed ID: 21691882
[TBL] [Abstract][Full Text] [Related]
8. Patients' self-reported adherence to cardiovascular medication using electronic monitors as comparators.
Zeller A; Ramseier E; Teagtmeyer A; Battegay E
Hypertens Res; 2008 Nov; 31(11):2037-43. PubMed ID: 19098375
[TBL] [Abstract][Full Text] [Related]
9. The Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Pilot Study on Glaucoma Medication Adherence.
Newman-Casey PA; Niziol LM; Lee PP; Musch DC; Resnicow K; Heisler M
Ophthalmol Glaucoma; 2020; 3(4):228-237. PubMed ID: 33012330
[TBL] [Abstract][Full Text] [Related]
10. Predicting Adherence With the Glaucoma Treatment Compliance Assessment Tool.
Sanchez FG; Mansberger SL; Newman-Casey PA
J Glaucoma; 2020 Nov; 29(11):1017-1024. PubMed ID: 32740508
[TBL] [Abstract][Full Text] [Related]
11. Adherence to Ocular Hypotensive Medication in Patients With Primary Open Angle Glaucoma in Ghana.
Kyei S; Kwao E; Mashige PK; Listowell Abu S; Racette L
J Glaucoma; 2023 Sep; 32(9):777-782. PubMed ID: 37079490
[TBL] [Abstract][Full Text] [Related]
12. Determinants of medication adherence to topical glaucoma therapy.
Dreer LE; Girkin C; Mansberger SL
J Glaucoma; 2012; 21(4):234-40. PubMed ID: 21623223
[TBL] [Abstract][Full Text] [Related]
13. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naïve, HIV patients.
Buscher A; Hartman C; Kallen MA; Giordano TP
HIV Clin Trials; 2011; 12(5):244-54. PubMed ID: 22180522
[TBL] [Abstract][Full Text] [Related]
14. Automated telecommunication-based reminders and adherence with once-daily glaucoma medication dosing: the automated dosing reminder study.
Boland MV; Chang DS; Frazier T; Plyler R; Jefferys JL; Friedman DS
JAMA Ophthalmol; 2014 Jul; 132(7):845-50. PubMed ID: 24831037
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Glaucoma Medication Adherence over Four Years of Follow-Up.
Newman-Casey PA; Blachley T; Lee PP; Heisler M; Farris KB; Stein JD
Ophthalmology; 2015 Oct; 122(10):2010-21. PubMed ID: 26319441
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
[TBL] [Abstract][Full Text] [Related]
17. Applying the resources and supports in self-management framework to examine ophthalmologist-patient communication and glaucoma medication adherence.
Sleath B; Carpenter DM; Blalock SJ; Sayner R; Muir KW; Slota C; Giangiacomo AL; Hartnett ME; Tudor G; Robin AL
Health Educ Res; 2015 Oct; 30(5):693-705. PubMed ID: 26338986
[TBL] [Abstract][Full Text] [Related]
18. The Impact of the Coronavirus Disease 2019 Pandemic on Adherence to Ocular Hypotensive Medication in Patients with Primary Open-Angle Glaucoma.
Racette L; Abu SL; Poleon S; Thomas T; Sabbagh N; Girkin CA
Ophthalmology; 2022 Mar; 129(3):258-266. PubMed ID: 34673098
[TBL] [Abstract][Full Text] [Related]
19. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.
Sleath B; Blalock S; Covert D; Stone JL; Skinner AC; Muir K; Robin AL
Ophthalmology; 2011 Dec; 118(12):2398-402. PubMed ID: 21856009
[TBL] [Abstract][Full Text] [Related]
20. Quantifying Glaucoma Medication Adherence: The Relationship Between Self-Report, Electronic Monitoring, and Pharmacy Refill.
Kumar JB; Bosworth HB; Sleath B; Woolson S; Olsen M; Danus S; Muir KW
J Ocul Pharmacol Ther; 2016; 32(6):346-54. PubMed ID: 27058842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
